Rockville, MD, United States of America

George W Wright

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 12.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal6 out of 3,435 
 
National Institutes of Health, a Component of the US Dept. of Health & Human Services
 patents
silverMedal5 out of 21 
 
Hospital Clinic De Barcelona
 patents
bronzeMedal4 out of 61 
 
British Columbia Cancer Agency Branch
 patents
44 out of 47 
 
UniversitÄt De Barcelona
 patents
54 out of 504 
 
Oregon Health & Science University
 patents
64 out of 6 
 
Julius-maximilians-university of Wurzburg
 patents
74 out of 11 
 
Oslo University Hospital Hf
 patents
83 out of 972 
 
University of Arizona
 patents
93 out of 1,036 
 
The Cleveland Clinic Foundation
 patents
103 out of 730 
 
University of Nebraska
 patents
112 out of 1,742 
 
Mayo Foundation for Medical Education and Research
 patents
121 out of 3 
 
British Columbia Cancer Agency
 patents
131 out of 1 
 
Universitat De Barceloa
 patent
141 out of 1 
 
Institut D'investigacions Biomédiques Pi I Sunyer (Idibaps)
 patent
151 out of 1 
 
Robert Bosch Gesellschaft Feuer Medizinische Forshung Mbh
 patent
161 out of 639 
 
City of Hope
 patents
171 out of 88 
 
University of London
 patents
181 out of 970 
 
University of Rochester
 patents
where one patent can have more than one assignee

Years Active: 2019-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of George W. Wright

Introduction

George W. Wright is a notable inventor based in Rockville, MD, who has made significant contributions to the field of medical research, particularly in the area of lymphoma treatment. With a total of six patents to his name, his work focuses on improving the understanding and treatment of mantle cell lymphoma (MCL).

Latest Patents

Among his latest patents is the invention titled "Evaluation of mantle cell lymphoma and methods related thereto." This invention provides methods for determining a survival predictor score for subjects diagnosed with MCL. It also includes methods for predicting survival outcomes and selecting appropriate treatments for patients with this condition. Another significant patent is the "Method for determining lymphoma type and providing treatment," which offers a way to distinguish between different types of lymphoma based on gene expression measurements. This invention can differentiate between primary mediastinal large B-cell lymphoma (PMBCL) and diffuse large B-cell lymphoma (DLBCL), as well as further classify DLBCL subtypes, aiding in targeted treatment approaches.

Career Highlights

George W. Wright has had a distinguished career, working with prestigious organizations such as the National Institutes of Health, a component of the U.S. Department of Health & Human Services, and Hospital Clinic De Barcelona. His work in these institutions has allowed him to contribute to groundbreaking research in oncology.

Collaborations

Throughout his career, Wright has collaborated with esteemed colleagues, including Louis M. Staudt and Lisa M. Rimsza, who have also made significant contributions to the field of lymphoma research.

Conclusion

George W. Wright's innovative patents and collaborative efforts have greatly advanced the understanding and treatment of lymphoma, showcasing his dedication to improving patient outcomes in this challenging area of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…